|
|
|
Cambridge Healthtech Institute, Washington, DC
2015-08-18
The Next Generation Dx Summit, entering its seventh year, brings together more than 800 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, this year’s expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer immunotherapy, and reimbursement. With widespread coverage of all the most relevant diagnostics topics, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field.
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
Invited Speakers:
|
|
- Edward R. Damiano, Ph.D., Professor, Biomedical Engineering, Boston University
- Gyorgy Abel, M.D., Ph.D., Director, Molecular Diagnostics, Immunology & Clinical Chemistry, Laboratory Medicine, Lahey Hospital & Medical Center
- Matthew C. Lorence, Ph.D., Executive Vice President, Marketing and Sales, Edge Biosystems, Inc.
- Wilbur A. Lam, M.D., Ph.D., Assistant Professor, Pediatrics and Biomedical Engineering, Emory University and Georgia Institute of Technology
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2015-07-15
|
|
|
|
|
|
Registration:
|
|
For more information or to register, visit: http://www.nextgenerationdx.com/
|
|
|
|
|
|
|
|